UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Zimmer Biomet
ZBH
$18.8B
| $66.8M | 0.06% |
606,896
-60,567
| -9% | -$6.38M |
|
|
MJN
327
DELISTED
Mead Johnson Nutrition Company
MJN
| $66.7M | 0.06% |
662,957
+267
| +0% | +$26.6K |
|
|
IPXL
328
DELISTED
Impax Laboratories, Inc.
IPXL
| $66.6M | 0.06% |
2,102,479
-129,935
| -6% | -$3.8M |
|
329
Essex Property Trust
ESS
$18.4B
| $66.5M | 0.06% |
321,932
-5,420
| -2% | -$1.07M |
|
|
BBBY
330
DELISTED
Bed Bath & Beyond Inc
BBBY
| $66M | 0.06% |
866,716
-8,993
| -1% | -$628K |
|
331
Dollar Tree
DLTR
$24.9B
| $65.9M | 0.06% |
936,807
+905
| +0.1% | +$57.1K |
|
332
Xerox
XRX
$411M
| $65.9M | 0.06% |
1,804,625
-24,273
| -1% | -$856K |
|
333
MDU Resources
MDU
$4.2B
| $65.8M | 0.06% |
7,360,059
+1,532,515
| +26% | +$14.8M |
|
334
Delta Air Lines
DAL
$60.2B
| $65.8M | 0.06% |
1,336,834
-55,355
| -4% | -$2.33M |
|
335
Analog Devices
ADI
$176B
| $65.5M | 0.06% |
1,180,128
-148,954
| -11% | -$7.61M |
|
336
Kohl's
KSS
$2.28B
| $64.3M | 0.06% |
1,054,009
-136,952
| -11% | -$7.92M |
|
337
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
| – | – |
0
| – | – |
|
338
Alkermes
ALKS
$8.31B
| $64M | 0.06% |
1,093,489
+90,800
| +9% | +$4.63M |
|
339
Netflix
NFLX
$305B
| $63.9M | 0.06% |
13,100,640
-35,770
| -0.3% | -$192K |
|
340
W.W. Grainger
GWW
$64.7B
| $63.9M | 0.06% |
250,776
+12,199
| +5% | +$3.01M |
|
|
CERN
341
DELISTED
Cerner Corp
CERN
| $63.8M | 0.06% |
986,455
-7,697
| -0.8% | -$479K |
|
342
Whirlpool
WHR
$2.54B
| $63.7M | 0.06% |
328,546
-37,549
| -10% | -$6.45M |
|
|
STJ
343
DELISTED
St Jude Medical
STJ
| $63.6M | 0.06% |
978,451
+15,236
| +2% | +$981K |
|
344
Amphenol
APH
$201B
| $63.5M | 0.06% |
4,720,072
-20,000
| -0.4% | -$256K |
|
|
LO
345
DELISTED
LORILLARD INC COM STK
LO
| $62.9M | 0.06% |
999,991
-4,981
| -0.5% | -$308K |
|
346
Principal Financial Group
PFG
$24.6B
| $62.6M | 0.06% |
1,206,117
+100,251
| +9% | +$5.2M |
|
347
Marriott International
MAR
$90.4B
| $62.5M | 0.06% |
801,131
-3,290
| -0.4% | -$243K |
|
|
WFM
348
DELISTED
Whole Foods Market Inc
WFM
| $62.3M | 0.06% |
1,236,206
+17,654
| +1% | +$778K |
|
349
Illumina
ILMN
$29.9B
| $62.3M | 0.06% |
347,095
+14,178
| +4% | +$2.5M |
|
|
FITB
350
Fifth Third Bancorp
FITB
$51.6B
| $61.9M | 0.06% |
3,038,985
-138,871
| -4% | -$2.76M |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.